Smallpox (Vaccinia) Vaccine, Live
- Generic Name
- Smallpox (Vaccinia) Vaccine, Live
- Brand Names
- Acam2000
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 4SV59689SK
Overview
The New York City Board of Health strain of Vaccinia is a viral strain used as a component of some smallpox vaccinations. ACAM2000, a percutaneously administered smallpox vaccine that was approved by the FDA in 2007, contains live antigens of this strain.
Background
The New York City Board of Health strain of Vaccinia is a viral strain used as a component of some smallpox vaccinations. ACAM2000, a percutaneously administered smallpox vaccine that was approved by the FDA in 2007, contains live antigens of this strain.
Indication
The live antigen of the New York City Board of Health strain of Vaccinia is indicated (within the ACAM2000 formulation) for active immunization against smallpox disease in patients determined to be at high risk of contracting smallpox infection.
Associated Conditions
- Variola Major (Smallpox)
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.